While, in our study, by administration of the LOX recombinant protein (rhLOX) before and after the tail vein injection of PC3 tumor cells (a CRPC cell line), we showed that rhLOX treatment may reduce the tumor metastasis probability, and consistent with the in vitro cell migration data we presented. This evidence concerns the gene LOX and neoplasm.